Dual-targeting HER2 and PD-L1 CAR-T
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dual-targeting HER2 and PD-L1 CAR-T, covering 2024-10-30 to 2024-10-30. Get the full timeline:
Most recent: Clinical Trial Update: Dual-targeting HER2 and PD-L1 CAR-T for Solid Tumors [EARLY_Phase 1]